Month: November 2013

  • Algorithm Improves Activity Tracking for Wellness Apps

    Engineers and physiologists at Northwestern University in Chicago developed an algorithm to improve the way health and wellness apps on smartphones track a user’s physical movements. Professor of physical medicine and rehabilitation Konrad Kording, with colleagues Stephen Antos and Mark Albert, published an advance version of their findings online in the Journal of Neuroscience Methods…

  • Software Design Found to Influence Lab Test Choices

    A psychologist at University of Missouri in Columbia found the design of software used by physicians influences their choice of diagnostic tests when admitting new patients to hospitals, with implications for the quality of patient care and health care costs. Victoria Shaffer in Missouri’s Department of Health Sciences, with Adam Probst from Baylor Scott &…

  • FDA Approves Leukemia Treatment, First Breakthrough Therapy

    The U.S. Food and Drug Administration on Friday approved an antibody designed to treat chronic lymphocytic leukemia, when taken with chemotherapy. Obinutuzumabm — developed and marketed as the brand name Gazyva by the biotechnology company Genentech, a division of Roche in South San Francisco, California — is the first drug designated as a breakthrough therapy approved…

  • Strategy Sought to Encourage New Anticoagulant Prescriptions

    A new challenge on InnoCentive is looking for new ways to encourage physicians to prescribe anticoagulant drugs other than the commonly used warfarin for decreasing the formation of blood clots in people with atrial fibrillation. The competition has a total purse of $7,500 and a deadline of 27 November 2013. InnoCentive in Waltham, Massachusetts conducts…

  • Automated System Developed to Monitor Drug-Induced Comas

    Engineers at Massachusetts Institute of Technology and medical researchers at Massachusetts General Hospital in Boston developed and tested in lab animals a system connecting the brain to a drug infusion device that automatically controls anesthesia drugs administered to patients in a drug-induced coma. The team led by MIT engineering professor Emery Brown, who is also…